Practical Assessment of Psoriasis Clinical Severity in both Clinical Trials and Clinical Practice Settings: A Report from the GRAPPA 2016 Annual Meeting

被引：2

作者：

Merola, Joseph F. ^{[1
]}

Gottlieb, Alice B. ^{[2
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol, Dept Dermatol & Med, 75 Francis St, Boston, MA 02115 USA

[2] New York Med Coll, Dermatol, Valhalla, NY 10595 USA

来源：

JOURNAL OF RHEUMATOLOGY | 2017年 / 44卷 / 05期

关键词：

PSORIATIC ARTHRITIS; PSORIASIS; COMBINED CLINIC; GRAPPA; EFFICACY; MODERATE; AREA;

D O I：

10.3899/jrheum.170147

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

At the 2016 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), we presented the case for quantitatively assessing the extent of both psoriasis and psoriatic arthritis in the clinical setting, with a particular focus on the validation and expanded novel use of the PGAxBSA (static physician's global assessment x body surface area of involvement) in the era of targeted metrics. Herein, we summarize our presentation.

引用

页码：691 / 692

页数：2

共 50 条

[31] Development of Simple Clinical Criteria for the Definition of Inflammatory Arthritis, Enthesitis, Dactylitis, and Spondylitis: A Report from the GRAPPA 2014 Annual Meeting
Mease, Philip J.
Park, Jane J.
Garg, Amit
Gladman, Dafna D.
Helliwell, Philip S.
JOURNAL OF RHEUMATOLOGY, 2015, 42 (06) : 1041 - 1043
[32] Development of Simple Clinical Criteria for the Definition of Inflammatory Arthritis, Enthesitis, Dactylitis, and Spondylitis: A Report from the GRAPPA 2012 Annual Meeting
Mease, Philip J.
Garg, Amit
Gladman, Dafna D.
Helliwell, Philip S.
JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) : 1442 - 1445
[33] Treat-to-target and Improving Outcomes in Psoriasis: A Report from the GRAPPA 2014 Annual Meeting
Takeshita, Junko
Armstrong, April W.
Mease, Philip J.
Gelfand, Joel M.
JOURNAL OF RHEUMATOLOGY, 2015, 42 (06) : 1037 - 1040
[34] Abbreviated cognitive and functional assessment in clinical practice and clinical trials
Velligan, Dawn
Patterson, Thomas L.
Nuechterlein, Keith H.
BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 36S - 36S
[35] From clinical trials to clinical practice - Why the gap?
Kotchen, Theodore A.
HYPERTENSION, 2006, 48 (02) : 196 - 197
[36] From clinical trials to clinical practice - Bridging the GAP
Rich, MW
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10): : 1321 - 1323
[37] From clinical trials to clinical practice in cerebrovascular disease
Hachinski, V
5TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2000, : 139 - 142
[38] The COACH program: From clinical trials to clinical practice
Vale, MJ
Jelinek, MV
Best, JD
Hoekstra, MB
Rizzuto, A
Thompson, K
Grigg, LE
Hare, DL
CIRCULATION, 2004, 109 (20) : E296 - E296
[39] Clinical benefits in patients with psoriasis after efalizumab therapy: Clinical trials versus practice
Ricardo, RR
Rhoa, M
Orenberg, EK
Li, N
Rundle, AC
Caro, I
CUTIS, 2004, 74 (03): : 193 - 200
[40] Patient Participation in Psoriasis and Psoriatic Arthritis Outcome Research: A Report from the GRAPPA 2013 Annual Meeting
de Wit, Maarten
Campbell, Willemina
FitzGerald, Oliver
Gladman, Dafna D.
Helliwell, Phillip S.
James, Jana
Lindsay, Chris
MacDonald, Roland
McHugh, Neil J.
Mease, Philip J.
Orbai, Ana-Maria
Palominos, Penelope
Parkinson, Andrew
Tillett, William
Goel, Niti
JOURNAL OF RHEUMATOLOGY, 2014, 41 (06) : 1206 - 1211

← 1 2 3 4 5 →